THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorThe University of Texas Medical Branch, Galveston
About this trial
The study's purpose is to evaluate whether creatine supplementation can help breast cancer survivors respond quicker to exercise by improving strength, endurance, and body composition. We are seeking to compare information collected from healthy woman of the same age who have never had breast cancer to those participants who have had breast cancer and undergone chemotherapy treatment.
Eligibility criteria
Qualifiers
Age 18-75 years of age
Diagnosis of breast cancer requiring chemotherapy
Recent (within 6 months) completion of chemotherapy
Willing to attend 3 virtual-based exercise sessions per week
Disqualifiers
Physical indications where performing exercise may be limited and/or contraindicated
Poorly controlled hypertension (blood pressure > 160/95mmHg)
Current tobacco use (within 6 months)
Anabolic steroids use
Trial design
Treatments tested in this trial
- Creatine
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
The University of Texas Medical Branch, Galveston
Lead sponsor
ThriveWell Cancer Foundation
Collaborator
Source ClinicalTrials.gov